Luxury experts say aspirational luxury consumers are facing new pressures from inflation and a slowing job market, meaning fewer Birkin buyers at auction.
Pfizer has pursued deals of all sizes to build new revenue streams, but the outlook underscores that those investments are still some distance from paying off.